Novogen of Australia Reports Favorable Trial For Pancreatic Cancer Drug
This article was originally published in PharmAsia News
Executive Summary
Australia's Novogen said it received favorable reports from trials on its triphendiol for treating pancreatic cancer. The drug was tried in combination with Eli Lilly's Gemzar (gemcitabine hydrochloride). The Sydney-based company recently announced positive results for its promensil product for maintaining ovarian cancer remission in addition to its use for treating menopausal symptoms. (Click here for more